#Endo international stock reddit plus

Endo's India-based entities are not part of the Chapter 11 proceedings. Bankruptcy Court for the Southern District of New York ('Court'). To facilitate the sale process and provide an appropriate forum for bringing closure to opioid-related and other uncertainties without the need for continued costly, time-consuming litigation, Endo and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in the U.S. This 'stalking horse' bid will be subject to higher or otherwise better offers. Have net funded leverage in an amount no greater than 4.5x. Offer employment to all of Endo's active team members Įstablish voluntary trusts, to be funded with $550 million over 10 years, whereby future proceeds will be set aside for certain opioid claims and The transaction contemplates that the purchaser will:

#Endo international stock reddit plus

Under the RSA, the debtholder group has committed to providing total purchase consideration of approximately $6 billion in the form of a credit bid, plus assumption of certain liabilities, for substantially all of the Company's assets. This will allow Endo to advance its business transformation with a strengthened balance sheet to create compelling value for its stakeholders over the long term. Patients and Customers Will Continue to Receive Highest Quality Products and Excellent ServiceĪmple Liquidity to Fund Day-to-Day Operations and Ordinary Course Investments During Court-Supervised ProcessĭUBLIN, AUGEndo International plc (NASDAQ: ENDP) ('Endo' or the 'Company') today announced that it has entered into a restructuring support agreement ('RSA') with holders of more than a majority of Endo's first lien debt on a sale transaction that would substantially reduce outstanding indebtedness, address remaining opioid and other litigation-related claims, and best position Endo for the future. Trusts Funded with $550 Million to Benefit Opioid Claimants Sale Transaction Would Result in a Substantial Reduction of Debt and Contemplates Purchaser-Established Voluntary This valuation marks a discount compared to its industry's average Forward P/E of 14.9.Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthenįinancial Position and Advance Ongoing Business Transformation In terms of valuation, Endo International is currently trading at a Forward P/E ratio of 1.46.

Endo International currently has a Zacks Rank of #3 (Hold). Over the past month, the Zacks Consensus EPS estimate has moved 7.31% lower. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. Our research shows that these estimate changes are directly correlated with near-term stock prices. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. Recent revisions tend to reflect the latest near-term business trends. It is also important to note the recent changes to analyst estimates for Endo International. Meanwhile, our latest consensus estimate is calling for revenue of $734.44 million, down 3.39% from the prior-year quarter. On that day, Endo International is projected to report earnings of $0.67 per share, which would represent a year-over-year decline of 10.67%. Endo International will be looking to display strength as it nears its next earnings release.